Patricia M. Adams

Vice President-Human Resources & Administration at Aptinyx, Inc.

Patricia M. Adams

Patricia M. Adams

Vice President-Human Resources & Administration at Aptinyx, Inc.

Overview
RelSci Relationships

59

Relationships
RelSci Relationships are individuals Patricia M. Adams likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President, Chemistry R&D at Aptinyx, Inc.

Relationship likelihood: Strong

Vice President-Research at Aptinyx, Inc.

Relationship likelihood: Strong

Chief Marketing Officer at Aptinyx, Inc.

Relationship likelihood: Strong

Chief Development Officer at Aptinyx, Inc.

Relationship likelihood: Strong

Chief Financial & Business Officer at Aptinyx, Inc.

Relationship likelihood: Strong

Director at Northwestern University - Falk Center for Molecular Therapeutics at Robert R. McCormick School of Engineering and Applied Science

Relationship likelihood: Strong

President & Chief Executive Officer at Aptinyx, Inc.

Relationship likelihood: Strong

Chief Commercial Officer at Aptinyx, Inc.

Relationship likelihood: Average

Chief Executive Officer at Anagin, Inc.

Relationship likelihood: Average

Advisory Partner at Relmada Therapeutics, Inc.

Relationship likelihood: Average

Paths to Patricia M. Adams
Potential Connections via
Relationship Science
You
Patricia M. Adams
Vice President-Human Resources & Administration at Aptinyx, Inc.
Education
Master's Degree in Human Resources

Loyola University Chicago, a private university founded in 1870 as St. Ignatius College, is one of the nation’s largest Jesuit, Catholic Universities and the only one located in Chicago. Loyola University Chicago comprises four campuses: Lake Shore (LSC), Water Tower (WTC), Health Sciences (HSC), and the John Felice Rome Center in Italy, and is home to ten schools and colleges: Quinlan School of Business, Marcella Niehoff School of Nursing, Stritch School of Medicine, College of Arts and Sciences, School of Communication, School of Continuing and Professional Studies, School of Education, School of Law, School of Social Work, and Graduate School. Loyola also features course locations in Beijing, China; Saigon-Ho Chi Minh City, Vietnam; Vernon Hills, Illinois (Cuneo Mansion and Gardens); and a Retreat and Ecology Campus in Woodstock, Illinois.

Career History
Vice President-Human Resources & Administration
Current

Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.

Vice President, Human Resources
Prior - 2015

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Vice President, Human Resources
2011 - Prior

BioSante´s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations and other business combinations or transactions with other pharmaceutical and biotechnology companies. BioSante´s products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III development. BioSante also is developing a portfolio of cancer vaccines, with 17 Phase I and Phase II clinical trials currently on-going. Four of these vaccines have been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA). BioSante´s other products include an FDA-approved testosterone gel for male hypogonadism, which is licensed to Teva Pharmaceuticals USA, Inc., and the Pill-Plus™, an oral contraceptive in Phase II clinical development by Pantarhei Bioscience B.V. BioSante´s first FDA-approved product, Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, is marketed in the U.S. by Meda Pharmaceuticals, BioSante´s licensee.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patricia M. Adams. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patricia M. Adams's profile does not indicate a business or promotional relationship of any kind between RelSci and Patricia M. Adams.